‘Industrializing the production of cells’: Another iPSC player joins the quest for off-the-shelf cell therapies February 16, 2021 · by Aviatior · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. · CEO David Main (Notch) https://endpts.com/industrializing-the-production-of-cells-another-ipsc-player-joins-the-quest-for-off-the-shelf-cell-therapies/ Share this:Share on TumblrTweetWhatsAppTelegramEmailPrintMorePocketLike this:Like Loading... Related